Home / TB / Multimedia

16/07/14

South Africa’s shrinking options for drug-resistant TB

By: Meera Senthilingam

Republish

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

Tuberculosis is the leading cause of death in South Africa due, in part, to the high prevalence of HIV. Today, the country faces the additional problem of TB bacteria becoming resistant to all available antibiotics. Doctors are running out of treatment options and, as they await new drugs and vaccines, reducing transmission becomes a crucial component of disease control. This audio slideshow investigates the problem in the townships of Cape Town.

Reporting made possible in part by the Pulitzer Center on Crisis Reporting.